Discovery of a novel AcrAB-TolC pump inhibitor using the multistep virtual screening, synthesis and biological evaluation of asymmetric imidazole-4,5-dicarboxamide derivatives

Author:

Phan Thien-Vy12,Huynh Phuong Nguyen Hoai1,Nguyen Vu-Thuy-Vy12,Nguyen Thanh-Phuc1,Vu Thanh-Thao1,Thi Vo Cam-Van1ORCID,Le Minh-Tri13,Nguyen Bao Gia Dang4ORCID,Truong Phuong1,Thai Khac-Minh1ORCID

Affiliation:

1. Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, 41 Dinh Tien Hoang St., Dist. 1, Ho Chi Minh City 700000, Vietnam

2. Department of Pharmacy, Nguyen Tat Thanh University, 300A Nguyen Tat Thanh St., Dist. 4, Ho Chi Minh City 700000, Vietnam

3. School of Medicine, Vietnam National University Ho Chi Minh City, Linh Trung Ward., Thu Duc Dist, Ho Chi Minh City, 700000, Vietnam

4. Imperial College London, London SW7 2AZ, UK

Abstract

By virtual screening, we identify the potential of asymmetric imidazole-4,5-dicarboxamide derivatives as E. coli-AcrB efflux pump inhibitors. The compounds are synthesized and their inhibitory activity is evaluated by a biological assay.

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,General Chemistry,Catalysis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3